MARKET

ELUT

ELUT

Elutia Inc.
NASDAQ
0.9871
+0.0446
+4.73%
After Hours: 1.020 +0.033 +3.33% 17:01 02/06 EST
OPEN
0.9412
PREV CLOSE
0.9425
HIGH
1.040
LOW
0.9412
VOLUME
161.74K
TURNOVER
--
52 WEEK HIGH
3.460
52 WEEK LOW
0.5000
MARKET CAP
42.25M
P/E (TTM)
-1.4459
1D
5D
1M
3M
1Y
5Y
1D
Two Elutia Insiders Just Made Bold Moves That Could Signal What’s Coming Next
TipRanks · 5d ago
Director and 10% Owner Kevin Rakin Acquires Common Shares of Elutia Inc
Reuters · 5d ago
Elutia Inc. Director Guido J. Neels Reports Acquisition of Common Shares
Reuters · 6d ago
Weekly Report: what happened at ELUT last week (0126-0130)?
Weekly Report · 6d ago
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga · 01/30 12:05
Elutia Director Makes Bold Move With Fresh Insider Stock Purchase
TipRanks · 01/30 02:03
Director Guido J. Neels Acquires Common Shares of Elutia Inc
Reuters · 01/29 22:51
Weekly Report: what happened at ELUT last week (0119-0123)?
Weekly Report · 01/26 09:22
More
About ELUT
Elutia Inc. is a commercial-stage company, which has developed a portfolio of products using both human and porcine tissue. Its portfolio of products spans the Women’s Health and Cardiovascular markets. In Women’s Health, it offers SimpliDerm, a novel biological matrix that leverages the inherent science of natural healing processes. SimpliDerm's design uses human-based hydrated acellular dermal matrix (ADM), which mitigates inflammation and enhances tissue incorporation. In Cardiovascular, it sells its specialized porcine small intestine submucosa for use as an intracardiac and vascular patch, as well as for pericardial reconstruction. In addition, its TYKE product is designed for use in the neonatal patient population. It is focused on advancing NXT-41x, a biomatrix that directly addresses the root causes of reconstruction infections following mastectomy. NXT-41x combines biologics and extended antibiotic release to provide protection while supporting tissue regeneration.

Webull offers Elutia Inc stock information, including NASDAQ: ELUT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ELUT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ELUT stock methods without spending real money on the virtual paper trading platform.